Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 3
1969 1
1973 2
1974 2
1975 4
1976 3
1977 6
1978 5
1979 6
1980 3
1981 5
1982 4
1983 7
1984 9
1985 6
1986 2
1987 3
1988 4
1989 5
1990 3
1992 5
1993 1
1994 2
1995 1
1996 10
1997 6
1998 9
1999 6
2000 6
2001 15
2002 10
2003 12
2004 17
2005 16
2006 4
2007 10
2008 11
2009 17
2010 6
2011 5
2012 5
2013 5
2014 13
2015 8
2016 6
2017 6
2018 8
2019 6
2020 2
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

296 results
Results by year
Filters applied: . Clear all
Page 1
Heart Rate and Rhythm and the Benefit of Beta-Blockers in Patients With Heart Failure.
Kotecha D, Flather MD, Altman DG, Holmes J, Rosano G, Wikstrand J, Packer M, Coats AJS, Manzano L, Böhm M, van Veldhuisen DJ, Andersson B, Wedel H, von Lueder TG, Rigby AS, Hjalmarson Å, Kjekshus J, Cleland JGF; Beta-Blockers in Heart Failure Collaborative Group. Kotecha D, et al. Among authors: wedel h. J Am Coll Cardiol. 2017 Jun 20;69(24):2885-2896. doi: 10.1016/j.jacc.2017.04.001. Epub 2017 Apr 30. J Am Coll Cardiol. 2017. PMID: 28467883 Free article. Review.
Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery.
Sjöström L, Lindroos AK, Peltonen M, Torgerson J, Bouchard C, Carlsson B, Dahlgren S, Larsson B, Narbro K, Sjöström CD, Sullivan M, Wedel H; Swedish Obese Subjects Study Scientific Group. Sjöström L, et al. Among authors: wedel h. N Engl J Med. 2004 Dec 23;351(26):2683-93. doi: 10.1056/NEJMoa035622. N Engl J Med. 2004. PMID: 15616203 Free article. Clinical Trial.
Beta-blockers for heart failure with reduced, mid-range, and preserved ejection fraction: an individual patient-level analysis of double-blind randomized trials.
Cleland JGF, Bunting KV, Flather MD, Altman DG, Holmes J, Coats AJS, Manzano L, McMurray JJV, Ruschitzka F, van Veldhuisen DJ, von Lueder TG, Böhm M, Andersson B, Kjekshus J, Packer M, Rigby AS, Rosano G, Wedel H, Hjalmarson Å, Wikstrand J, Kotecha D; Beta-blockers in Heart Failure Collaborative Group. Cleland JGF, et al. Among authors: wedel h. Eur Heart J. 2018 Jan 1;39(1):26-35. doi: 10.1093/eurheartj/ehx564. Eur Heart J. 2018. PMID: 29040525 Free PMC article.
Bariatric surgery and long-term cardiovascular events.
Sjöström L, Peltonen M, Jacobson P, Sjöström CD, Karason K, Wedel H, Ahlin S, Anveden Å, Bengtsson C, Bergmark G, Bouchard C, Carlsson B, Dahlgren S, Karlsson J, Lindroos AK, Lönroth H, Narbro K, Näslund I, Olbers T, Svensson PA, Carlsson LM. Sjöström L, et al. Among authors: wedel h. JAMA. 2012 Jan 4;307(1):56-65. doi: 10.1001/jama.2011.1914. JAMA. 2012. PMID: 22215166
Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial.
Sever PS, Dahlöf B, Poulter NR, Wedel H, Beevers G, Caulfield M, Collins R, Kjeldsen SE, Kristinsson A, McInnes GT, Mehlsen J, Nieminen M, O'Brien E, Ostergren J; ASCOT investigators. Sever PS, et al. Among authors: wedel h. Lancet. 2003 Apr 5;361(9364):1149-58. doi: 10.1016/S0140-6736(03)12948-0. Lancet. 2003. PMID: 12686036 Clinical Trial.
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.
Dahlöf B, Devereux RB, Kjeldsen SE, Julius S, Beevers G, de Faire U, Fyhrquist F, Ibsen H, Kristiansson K, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Wedel H; LIFE Study Group. Dahlöf B, et al. Among authors: wedel h. Lancet. 2002 Mar 23;359(9311):995-1003. doi: 10.1016/S0140-6736(02)08089-3. Lancet. 2002. PMID: 11937178 Clinical Trial.
Effects of bariatric surgery on mortality in Swedish obese subjects.
Sjöström L, Narbro K, Sjöström CD, Karason K, Larsson B, Wedel H, Lystig T, Sullivan M, Bouchard C, Carlsson B, Bengtsson C, Dahlgren S, Gummesson A, Jacobson P, Karlsson J, Lindroos AK, Lönroth H, Näslund I, Olbers T, Stenlöf K, Torgerson J, Agren G, Carlsson LM; Swedish Obese Subjects Study. Sjöström L, et al. Among authors: wedel h. N Engl J Med. 2007 Aug 23;357(8):741-52. doi: 10.1056/NEJMoa066254. N Engl J Med. 2007. PMID: 17715408 Free article.
Excess Mortality among Persons with Type 2 Diabetes.
Tancredi M, Rosengren A, Svensson AM, Kosiborod M, Pivodic A, Gudbjörnsdottir S, Wedel H, Clements M, Dahlqvist S, Lind M. Tancredi M, et al. Among authors: wedel h. N Engl J Med. 2015 Oct 29;373(18):1720-32. doi: 10.1056/NEJMoa1504347. N Engl J Med. 2015. PMID: 26510021 Free article.
Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project.
Conroy RM, Pyörälä K, Fitzgerald AP, Sans S, Menotti A, De Backer G, De Bacquer D, Ducimetière P, Jousilahti P, Keil U, Njølstad I, Oganov RG, Thomsen T, Tunstall-Pedoe H, Tverdal A, Wedel H, Whincup P, Wilhelmsen L, Graham IM; SCORE project group. Conroy RM, et al. Among authors: wedel h. Eur Heart J. 2003 Jun;24(11):987-1003. doi: 10.1016/s0195-668x(03)00114-3. Eur Heart J. 2003. PMID: 12788299
Efficacy of β blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis.
Kotecha D, Holmes J, Krum H, Altman DG, Manzano L, Cleland JG, Lip GY, Coats AJ, Andersson B, Kirchhof P, von Lueder TG, Wedel H, Rosano G, Shibata MC, Rigby A, Flather MD; Beta-Blockers in Heart Failure Collaborative Group. Kotecha D, et al. Among authors: wedel h. Lancet. 2014 Dec 20;384(9961):2235-43. doi: 10.1016/S0140-6736(14)61373-8. Epub 2014 Sep 2. Lancet. 2014. PMID: 25193873
296 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page